Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 222

1.

Research gaps in psoriasis: opportunities for future studies.

Ryan C, Korman NJ, Gelfand JM, Lim HW, Elmets CA, Feldman SR, Gottlieb AB, Koo JY, Lebwohl M, Leonardi CL, Van Voorhees AS, Bhushan R, Menter A.

J Am Acad Dermatol. 2014 Jan;70(1):146-67. doi: 10.1016/j.jaad.2013.08.042. Epub 2013 Oct 11. Review.

PMID:
24126079
2.

From the Medical Board of the National Psoriasis Foundation: The risk of cardiovascular disease in individuals with psoriasis and the potential impact of current therapies.

Hugh J, Van Voorhees AS, Nijhawan RI, Bagel J, Lebwohl M, Blauvelt A, Hsu S, Weinberg JM.

J Am Acad Dermatol. 2014 Jan;70(1):168-77. doi: 10.1016/j.jaad.2013.09.020. Epub 2013 Nov 1. Review.

PMID:
24184141
3.

Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions.

American Academy of Dermatology Work Group, Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, Gottlieb A, Koo JY, Lebwohl M, Leonardi CL, Lim HW, Van Voorhees AS, Beutner KR, Ryan C, Bhushan R.

J Am Acad Dermatol. 2011 Jul;65(1):137-74. doi: 10.1016/j.jaad.2010.11.055. Epub 2011 Feb 8. Review.

PMID:
21306785
4.

[Integrated approach to comorbidity in patients with psoriasis.Working Group on Psoriasis-associated Comorbidities].

Daudén E, Castañeda S, Suárez C, García-Campayo J, Blasco AJ, Aguilar MD, Ferrándiz C, Puig L, Sánchez-Carazo JL; Grupo de Trabajo en Comorbilidades asociadas a la Psoriasis.

Actas Dermosifiliogr. 2012 Jan;103 Suppl 1:1-64. doi: 10.1016/S0001-7310(12)70001-7. Spanish.

PMID:
22364603
5.

Psoriasis: comorbidities and associations.

Farley E, Menter A.

G Ital Dermatol Venereol. 2011 Feb;146(1):9-15. Review.

PMID:
21317853
6.

Psoriasis and its comorbidities.

Onumah N, Kircik LH.

J Drugs Dermatol. 2012 May;11(5 Suppl):s5-10. Review.

PMID:
22644770
7.

Psoriasis: a skin disease associated with increased cardiovascular risk.

González-Gay MA, González-Vela C, González-Juanatey C.

Actas Dermosifiliogr. 2012 Sep;103(7):595-8. Epub 2012 Mar 31. Review. English, Spanish.

PMID:
22465257
8.

Prologue: 2012 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).

Mease PJ, Boehncke WH, Gladman DD.

J Rheumatol. 2013 Aug;40(8):1407-9. doi: 10.3899/jrheum.130450.

PMID:
23908533
9.

Metabolic comorbidities and psoriasis.

Gisondi P, Ferrazzi A, Girolomoni G.

Acta Dermatovenerol Croat. 2010;18(4):297-304. Review.

PMID:
21251450
10.

Psoriasis and cardiovascular disorders.

Ryan C, Menter A.

G Ital Dermatol Venereol. 2012 Apr;147(2):179-87. Review.

PMID:
22481581
11.

[Comorbidities in psoriatic arthritis].

Boehncke WH, Boehncke S.

Z Rheumatol. 2013 Oct;72(8):779-83. doi: 10.1007/s00393-013-1189-7. German.

PMID:
23934051
12.

Cardiovascular comorbidities of psoriasis and psoriatic arthritis: a report from the GRAPPA 2012 annual meeting.

Armstrong AW, Gelfand JM, Boehncke WH, Armstrong EJ.

J Rheumatol. 2013 Aug;40(8):1434-7. doi: 10.3899/jrheum.130457.

PMID:
23908540
13.

[Co-morbidities in psoriasis vulgaris].

Boehncke WH, Buerger C, Boehncke S.

Hautarzt. 2009 Feb;60(2):116-21. doi: 10.1007/s00105-008-1663-3. Review. German.

PMID:
19151962
14.

Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis.

Husted JA, Thavaneswaran A, Chandran V, Eder L, Rosen CF, Cook RJ, Gladman DD.

Arthritis Care Res (Hoboken). 2011 Dec;63(12):1729-35. doi: 10.1002/acr.20627.

15.

Cardiovascular risk factors in high-need psoriasis patients and its implications for biological therapies.

Driessen RJ, Boezeman JB, Van De Kerkhof PC, De Jong EM.

J Dermatolog Treat. 2009;20(1):42-7. doi: 10.1080/09546630802225702.

PMID:
18649164
16.

Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities.

Ryan C, Kirby B.

Dermatol Clin. 2015 Jan;33(1):41-55. doi: 10.1016/j.det.2014.09.004. Review.

PMID:
25412782
17.

TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis.

Tobin AM, Kirby B.

BioDrugs. 2005;19(1):47-57. Review.

PMID:
15691217
18.

Can early treatment with biologicals modify the natural history of comorbidities?

Vena GA, Vestita M, Cassano N.

Dermatol Ther. 2010 Mar-Apr;23(2):181-93. doi: 10.1111/j.1529-8019.2010.01313.x. Review.

PMID:
20415826
19.

Psoriasis: classical and emerging comorbidities.

Oliveira Mde F, Rocha Bde O, Duarte GV.

An Bras Dermatol. 2015 Jan-Feb;90(1):9-20. doi: 10.1590/abd1806-4841.20153038. Review.

20.

Comorbidities significantly impact patients' preferences for psoriasis treatments.

Schmieder A, Schaarschmidt ML, Umar N, Terris DD, Goebeler M, Goerdt S, Peitsch WK.

J Am Acad Dermatol. 2012 Sep;67(3):363-72. doi: 10.1016/j.jaad.2011.08.023. Epub 2011 Oct 19.

PMID:
22015150
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk